Search results for "Ethanolamine Oleate"

showing 2 items of 2 documents

Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate : a retrospective study of 43 patients

2017

Background Although sclerotherapy is a common treatment for benign oral vascular lesions, there is no well-standardized protocol for this purpose. The aim of the present study was to describe the clinical characteristics of patients treated by sclerotherapy with ethanolamine oleate (EO), in order to contribute to a better understanding of this technique. Material and Methods Medical records and images of 90 patients treated by the same sclerotherapy protocol were retrieved and analysed. Thus, 43 cases with complete information were selected and described. Results The most affected age group was 41–70 years, with a female predominance and 86% of patients being Caucasian. Lips were the most a…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentOleic AcidsGastroenterologyCongenital AbnormalitiesLesion03 medical and health sciencesYoung Adult0302 clinical medicineTongueInternal medicineSclerotherapymedicineSclerotherapyHumansYoung adultEthanolamine OleateChildGeneral DentistryAgedRetrospective StudiesMouthOral Medicine and Pathologybusiness.industryMedical recordResearchClinical appearanceRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Sclerosing Solutionsmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASBlood VesselsSurgeryFemaleMouth Neoplasmsmedicine.symptombusinessHemangioma
researchProduct

What is the preferred concentration of ethanolamine oleate for sclerotherapy of oral vascular anomalies?

2020

Background This study compared three different concentrations of EO (1.25%, 2.5% and 5%) for the treatment of oral vascular anomalies (OVAs). Material and Methods This was a retrospective comparative analysis of patients with OVAs treated with EO. Anomalies smaller than 20 mm were included. The patients were treated with 1.25% (G1), 2.5% (G2), and 5% (G3) and clinical data were obtained. The number of sessions, the final volume and dose of EO were statistically analyzed to verify effectiveness and safety of the treatment. The different concentrations of EO were compared considering the number of sessions, the final volume and total dose of EO. Analysis of covariance (ANCOVA) was used to eva…

Malemedicine.medical_specialtymedicine.medical_treatmentTreatment outcomeUrologyOleic Acids03 medical and health sciences0302 clinical medicineSclerotherapySclerotherapyHumansMedicineEthanolamine OleateGeneral DentistryRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Sclerosing SolutionsTreatment OutcomeOtorhinolaryngologyTotal doseUNESCO::CIENCIAS MÉDICASFemaleSurgerybusiness
researchProduct